• Science & Technology
• Health & Medicine

News digest - Cancer Drugs Fund, oxygen and lung cancer, breast cancer gene and more

More news on Government cancer drug funding, hyperactive gene linked to aggressive form of breast cancer and can oxygen cause lung cancer? More news on Government cancer drug funding, hyperactive gene linked to aggressive form of breast cancer and can oxygen cause lung cancer?

17 January 2015

• Health & Medicine

Improving the gold standard for brain tumours

We explore new research from our scientists testing a modified version of a brain cancer drug that could help overcome resistance to treatment. We explore new research from our scientists testing a modified version of a brain cancer drug that could help overcome resistance to treatment.

16 January 2015

• Health & Medicine

Does oxygen cause lung cancer? I wouldn’t hold your breath

Does living at high altitude prevent lung cancer? Our bloggers explore a new study that sparked headlines claiming oxygen might cause the disease. Does living at high altitude prevent lung cancer? Our bloggers explore a new study that sparked headlines claiming oxygen might cause the disease.

14 January 2015

• Health & Medicine

Cancer Drugs Fund decision – ‘How can we deliver personalised treatment with an impersonal funding system?’

Our chief clinician, Professor Peter Johnson, gives his take on the recent announcement of changes to NHS England's Cancer Drugs Fund. Our chief clinician, Professor Peter Johnson, gives his take on the recent announcement of changes to NHS England's Cancer Drugs Fund.

14 January 2015

• Health & Medicine

Revamped drug may overcome resistance in brain tumours

Cancer Research UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults. Cancer Research UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults.

14 January 2015

• Science & Technology

Gene linked to aggressive breast cancer

UK scientists have linked an overactive gene to an aggressive type of breast cancer. UK scientists have linked an overactive gene to an aggressive type of breast cancer.

12 January 2015

• Science & Technology
• Health & Medicine

My role as independent chair of the Cancer Strategy Taskforce

Our chief executive, Harpal Kumar, has been invited to be the independent chair of a new Cancer Strategy Taskforce - here he explains what that will involve. Our chief executive, Harpal Kumar, has been invited to be the independent chair of a new Cancer Strategy Taskforce - here he explains what that will involve.

11 January 2015

• Science & Technology
• Health & Medicine

News digest – ‘bad luck’, cancer drugs, 2.5 million people living with cancer and more

Tough news on Government cancer drug funding, 2.5 million people living with cancer in 2015 and is cancer ‘mainly bad luck’? Here’s the week’s cancer news. Tough news on Government cancer drug funding, 2.5 million people living with cancer in 2015 and is cancer ‘mainly bad luck’? Here’s the week’s cancer news.

10 January 2015

• Health & Medicine

The HOPON clinical trial: a patient’s view

In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean. In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean.

9 January 2015

• Health & Medicine

The HOPON clinical trial: the research nurses’ role

In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool. In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool.

8 January 2015

• Health & Medicine

The HOPON clinical trial: the doctor’s perspective

In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012. In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012.

7 January 2015

• Health & Medicine

More than a third of people with abnormal results drop out of bowel cancer screening

Almost 40 per cent of people who have abnormal results from bowel cancer screening tests ignore their next screening invitation two years later. Almost 40 per cent of people who have abnormal results from bowel cancer screening tests ignore their next screening invitation two years later.

7 January 2015